Antibiotic Therapy in Respiratory Tract Infections (RTIs)
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (30 June 2025) | Viewed by 770
Special Issue Editors
Interests: antibiotics; antimicrobial resistance; respiratory diseases; microbiome; public health
Special Issue Information
Dear Colleagues,
Respiratory tract infections (RTIs) are among the most common infectious diseases worldwide and represent a major global health burden. They cause significant morbidity, mortality, and healthcare costs worldwide. Antibiotic therapy remains key for the treatment of RTIs, but its use is often restricted by the growing threat of antimicrobial resistance due to overuse, inadequate prescribing practices, and diagnostic difficulties.
This special issue will explore the challenges and recent developments in antibiotic therapy for RTIs, including novel diagnostic tools, different aspects of RTI management, optimized dosing strategies, the effectiveness of innovations in the fight against antibiotic resistance in RTIs, mechanisms of resistance, impacts on host immunity and microbiome dynamics, antibiotic stewardship initiatives, and public health interventions.
Sharing results from this area of research will provide valuable insights into current clinical practices, barriers to compliance, and innovative strategies for improving patient care and therapeutic outcomes while mitigating risks associated with inappropriate antibiotic utilization.
Dr. Ágnes Tóth
Prof. Dr. Attila Csaba Nagy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic therapy
- respiratory tract infections
- clinical guidelines
- prescribing practices
- antibacterial resistance
- antimicrobial stewardship
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
